Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …

Background The utility of heated and humidified high-flow nasal oxygen (HFNO) for severe
COVID-19-related hypoxaemic respiratory failure (HRF), particularly in settings with limited …

Rationale: The “Berlin definition” of acute respiratory distress syndrome (ARDS) does not
allow inclusion of patients receiving high-flow nasal oxygen (HFNO). However, several …

Purpose We aimed to describe the use of high-flow nasal oxygen (HFNO) in patients with
COVID-19 acute respiratory failure and factors associated with a shift to invasive mechanical …

High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU |
European Respiratory Society Skip to main content Main menu Home Current issue ERJ Early …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-
CoV-2, which was first discovered in Wuhan, China. The disease has grown into a global …

Background The efficacy of high flow nasal canula oxygen therapy (HFNO) to prevent
invasive mechanical ventilation (IMV) is not well established in severe coronavirus disease …

To replace mechanical ventilation (MV), which represents the cornerstone therapy in severe
COVID-19 cases, high-flow nasal oxygen (HFNO) therapy has recently emerged as a less …

Objectives: An ongoing outbreak of coronavirus disease 2019 is spreading globally. Acute
hypoxemic respiratory failure is the most common complication of coronavirus disease 2019 …

Importance The benefit of high-flow nasal cannula oxygen (high-flow oxygen) in terms of
intubation and mortality in patients with respiratory failure due to COVID-19 is controversial …